// App-Quantinova.ai

: Understanding drivers of treatment preferences in locally advanced or metastatic urothelial carcinoma: A qualitative interview study with patients, caregivers, and physicians.

Researchers

Presenter

  • Andrea B. Apolo

Principal Investigators

  • Nicholas I. Simon

  • Mallory Farrar

  • Simrun Grewal

  • Zsolt Hepp

  • Lisa Mucha

  • Christine Michaels-Igbokwe

  • Sebastian Heidenreich

  • Katelyn Cutts

  • John L. Gore

Medical Centers

  • Evidera, Inc., London, United Kingdom

  • Evidera, Bethesda, MD

  • Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

  • Astellas Pharma, Inc., Northbrook, IL

  • Department of Radiology, University of Washington, Seattle, WA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Advanced Urothelial Carcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved